Sourcing outside a prescription: the honest risks

Why this page exists at all

Sunil opens the sourcing circle with the same sentence every fortnight, and it is worth putting at the top of this guide too: we are not here to help anybody buy anything. We are here because the question gets asked either way, and if a peer-support community refuses to answer it, the answer arrives instead from somebody with an order form and a conversion rate to hit.

So, the disclosures first, because they are the reason you can trust the rest. GLP Circle sells nothing. We broker nothing. No supplier has ever paid for a word on this site, no supplier is linked from any page of it, and the reference pages at our vendors section carry no recommendation, no ranking we would defend as meaningful, and no endorsement of any kind. They exist to record what members have reported and — much more importantly — to set out what cannot be checked.

What follows is the unflattering version. If you are looking for reassurance, this is not the page, and we would gently suggest that wanting reassurance is itself worth noticing. The community cannot make this safe. We can only make sure you are not deciding in the dark.

Research use only is not a technicality

Almost everything sold outside a prescription in this space is labelled research use only, or for laboratory research, or not for human consumption. People read that as legal cover and move on. It is not legal cover. It is an accurate description of the entire regulatory position of the vial, and it means something specific: the material was never manufactured, released or documented as a medicine.

Unpack that. No marketing authorisation was granted, which means no regulator ever assessed the quality, safety or efficacy of that product. No qualified person released the batch. No inspector walked the line that filled your vial, because for medicines that inspection is the mechanism by which sterility and cross-contamination control are assured, and research chemicals are outside it. There is no stability programme establishing how long the powder keeps or at what temperature. There is no pharmacovigilance system collecting reports of harm, so if the batch hurts twenty people, nothing anywhere connects those twenty reports. There is no recall route. And there is nobody who is accountable to you.

Compare that with a licensed pen. If a licensed batch is wrong there is a named manufacturer, a regulator with the power to compel a recall, a pharmacy that dispensed it, an adverse-event reporting scheme, and — in the last resort — a court. Every one of those is missing here. That absence is the product you are buying alongside the powder.

The five risks, named

Members find it easier to hold this as a short list than as a mood, so here is the list our quality circle uses.

• Identity. Whether the molecule in the vial is the molecule on the label. Related peptides, older-generation analogues and outright substitutions have all been documented in this market by testing programmes and by regulators.
• Content and dose accuracy. Not the same question as identity. Powder weight is not peptide weight — counterion, residual water and residual solvent all sit on the scales. A vial can be genuine, pure, and still contain materially less or more active peptide than the label implies.
• Sterility and endotoxin. You are injecting this. Lyophilised powder made for laboratory use is not required to be sterile and is not required to be low in bacterial endotoxin, and there is no home procedure that fixes either. A filter does not remove endotoxin. Alcohol on the stopper does not sterilise the contents.
• Contamination. Residual solvents from synthesis, elemental impurities from catalysts and equipment, and process-related peptide impurities — deletion sequences, truncations, aggregates. Licensed manufacture has explicit limits for these categories. Nothing sets a limit here.
• Recourse. If the batch is wrong you have a chat window and a payment method. That is the whole of your remedy.

You also become your own pharmacy

This is the risk members consistently under-price, because it is boring and it is theirs rather than the seller’s. Outside a prescription there is nobody between you and an arithmetic error.

You reconstitute the powder, so you choose the diluent volume, which sets the concentration, which sets what a mark on a syringe means. You label the vial, or you do not, and three vials into a fridge shelf they look identical. You decide how long a reconstituted multi-dose vial is still usable, with no stability data to decide it from. You judge whether a solution that looks slightly hazy is fine. Every one of those is a job that a manufacturer, a pharmacist and a leaflet normally do for you.

The error we hear about is not exotic. It is a decimal point at half past eleven at night, or a syringe graduated in insulin units being read as though the numbers meant milligrams, or a second dose given because the first one did not feel like it worked. If you are doing this, do the maths with somebody else in the room and check it cold the next morning — we wrote reconstitution, doing the maths together and built the reconstitution tool for exactly that, and neither of them can protect you from a mislabelled concentration on the vial you started from.

The law is not the same where you are as where we are

We will not tell you how to import anything, and the sourcing circle’s first agreement is that nobody helps anybody get a parcel through anything. What we will say is that the legal picture varies enormously and that people routinely misread it in a hopeful direction.

These molecules are prescription-only medicines in most of the places our members live. Some jurisdictions have a narrow personal-import allowance, some have none, and the ones that do generally attach conditions — a prescription, a quantity limit, a declaration — that a research-chemical order does not meet. Customs seizure is the ordinary outcome that people talk about; the less ordinary outcomes exist too, and the distinction between possessing something and supplying it matters almost everywhere. Handing a spare vial to a friend is supply in most legal systems, whatever your intention was.

Noor holds our regional circles and says the same thing to everyone: bring your own jurisdiction, because the confident answer somebody gave you was about theirs. This community cannot give legal advice and will not pretend otherwise.

What can actually be checked, and what cannot

The vendor reference pages are organised around two lists, and the second is the important one. Things that can be checked include whether a company trades where it says it trades, whether analysis documents exist and are internally consistent, whether members have reported parcels arriving with working tracking, and whether independently commissioned tests have landed near the published figures.

Things that cannot be checked, by us or by you: who actually synthesised the material and in what building; how many intermediaries handled it; whether the vial you were shipped came from the lot that was tested; the sterility and endotoxin status of anything, ever, because no purity panel addresses either; the temperature history of the parcel, whatever state the cold pack arrives in; batch-to-batch consistency over a year; and whether you have any recourse at all.

If you take one idea from this guide, make it that last cluster. A purity certificate is a statement about a sample. Your vial is not that sample. The gap between those two sentences is where nearly every misplaced confidence in this market lives, and what purity actually means takes it apart properly.

If you have already decided

Some of you have. We are not going to perform disapproval at you, because shame makes people hide symptoms, and hidden symptoms are how this goes badly. So, plainly:

• Tell whoever looks after your health. Clinicians have heard it. The consultation goes better than people expect, and it is the only way anything you develop gets attributed correctly.
• One thing at a time. Starting two unfamiliar substances in the same fortnight makes any reaction uninterpretable.
• Do not let cost drive your dosing. Stretching a vial, skipping steps upward because the next order is expensive, or splitting supplies with somebody else are all decisions made by a budget rather than by a body. Paying out of pocket without panic is Petra’s attempt at better options.
• Never share a vial, a needle or a pen. Not once, not with a partner.
• Know the red flags before you need them. When a symptom needs a clinician is short and we would rather you read it while nothing is wrong.
• Stop at anything odd. Particles, cloudiness that will not clear, a smell, a site reaction that spreads, fever after a dose. Do not reason your way past it.

And the sentence we repeat until it is boring, because it is the true one: nobody checked your dose, no regulator inspected the line, and no one is accountable to you.